New registry to monitor ablation therapy for Hard-to-Treat gut tumors

NCT ID NCT07625189

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is a registry that will follow 50 adults who are already scheduled to receive EUS-guided radiofrequency or microwave ablation for pancreatic or other gastrointestinal lesions as part of their routine care. Researchers will collect data from medical records to see how tumor size changes over time and how long patients live after the procedure. The goal is to gather real-world information on the safety and effectiveness of these ablation techniques.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
endoscopic ultrasound-guided radiofrequency ablation or microwave ablation
What this could lead to
If successful, this registry could help doctors understand how well these ablation techniques shrink tumors and improve survival for people with pancreatic or other gastrointestinal lesions.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the treatment works. Results may be limited by the small number of participants (50) and the lack of a comparison group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABLATION TECHNIQUES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • West Virginia University

    RECRUITING

    Morgantown, West Virginia, 26505, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.